June 28 2024 - ​​​​​Alumis cuts IPO size, but nets $250M for immune drug work

​​​​​Alumis cuts IPO size, but nets $250M for immune drug work
Philips BiPAP recall now linked to 65 deaths, 952 injuries
Where the future of Alzheimer's drugs is heading
House committee backs some Medicare cover for obesity drugs
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud